The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Changing trends in malignant transformation of hepatocellular adenoma
Abstract
Objective: Hepatocellular adenomas (HCAs) classically develop in women who are taking oral contraceptives and have a risk of malignant transformation into hepatocellular carcinoma (HCC). HCA with malignant transformation is, however, an ill-defined entity thought to be an anecdotic pathway to HCC. The objective of this study was to characterise malignancy occurring within HCA. Design, setting and patients: A series of histology proven HCAs managed between 1993 and 2008 in a tertiary hepato-biliary centre (218 patients, 184 women and 34 men) were screened to identify HCA with malignant transformation. Main outcome measures: The incidence of HCA with malignant transformation was analysed through the study period and associated conditions were retrieved. They were sub-typed according to their molecular features and the malignant compartment was mapped. Results: Areas of HCC within HCA were observed in 23 patients and the risk of malignant transformation was 4% in women and 47% in men. The number of women whose HCA had malignant changes has remained stable during the study period and oral contraception was the only associated condition. The number of men with such transformation has markedly increased since 2000 and the metabolic syndrome has become the most frequent associated condition. Two-thirds of HCAs with malignant transformation were β-catenin activated and one-third displayed cell atypias. Both features were more prevalent in men. The median diameter of HCA with malignancy was 10 cm and only three were 5 cm or less. Conclusion: Prevalence of malignancy within HCA is 10 times more frequent in men than in women and management of HCA should primarily be based on gender. Whereas oral contraception is a classical cause of HCA in women but a marginal cause of HCC, the metabolic syndrome appears as an emerging condition associated with malignant transformation of HCA in men, and is the likely predisposing condition for HCC in this setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · cited 1×
“As we have recently suspected a link between HCC and previous HCA in patients with a metabolic syndrome(18) we have also searched evidence for this syndrome according to the WHO criteria either retrospectively or by interview.(19) The pathological specimens of the 25 patients (the 23 of our own series and the two refe…”
MethodZucman-Rossi, J., Jeannot, E., Van Nhieu, J. T., Scoazec, J.-Y., Guettier, C., Rebouissou, S., Bacq, Y., Leteurtre, E., Paradis, V., Michalak, S., et al. (2006) · Hepatology · doi:10.1002/hep.21068 · Cited by 760
Self-citationPOSSIBLE ASSOCIATION BETWEEN BENIGN HEPATOMAS AND ORAL CONTRACEPTIVES
BAUM, J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92594-4 · Cited by 611
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry
Bioulac-Sage, P., Rebouissou, S., Thomas, C., Blanc, J.-F., Saric, J., Sa Cunha, A., Rullier, A., Cubel, G., Couchy, G., Imbeaud, S., et al. (2007) · Hepatology · doi:10.1002/hep.21743 · Cited by 590
Epidemiology of hepatocellular adenoma. The role of oral contraceptive use
Rooks, J. B. (1979) · JAMA · doi:10.1001/jama.242.7.644 · Cited by 588
Paradis, V., Zalinski, S., Chelbi, E., Guedj, N., Degos, F., Vilgrain, V., Bedossa, P., & Belghiti, J. (2009) · Hepatology · doi:10.1002/hep.22734 · Cited by 571
Self-citationHepatocellular adenoma management and phenotypic classification: The Bordeaux experience†
Bioulac‐Sage, P., Laumonier, H., Couchy, G., Le Bail, B., Sa Cunha, A., Rullier, A., Laurent, C., Blanc, J., Cubel, G., Trillaud, H., et al. (2009) · Hepatology · doi:10.1002/hep.22995 · Cited by 439
Metabolic syndrome and hepatocellular carcinoma: Two growing epidemics with a potential link
Siegel, A. B., & Zhu, A. X. (2009) · Cancer · doi:10.1002/cncr.24687 · Cited by 399 · cited 1×
“However, six of the 10 other men had a metabolic syndrome whereas this was never observed in women. This suggests that the metabolic syndrome is a new risk factor for malignant transformation within HCA and that HCC associated with the metabolic syndrome, which is a rising concern,”
A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas
Dokmak, S., Paradis, V., Vilgrain, V., Sauvanet, A., Farges, O., Valla, D., Bedossa, P., & Belghiti, J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.061 · Cited by 379
Self-citationObesity and incidence of cancer: a large cohort study of over 145 000 adults in Austria
Rapp, K., Schroeder, J., Klenk, J., Stoehr, S., Ulmer, H., Concin, H., Diem, G., Oberaigner, W., & Weiland, S. K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602819 · Cited by 332
Androgens and liver tumors: Fanconi's anemia and non‐Fanconi's conditions
Velazquez, I., & Alter, B. P. (2004) · American Journal of Hematology · doi:10.1002/ajh.20183 · Cited by 237
Monitoring the Obesity Epidemic in France: The Obepi Surveys 1997–2006
Charles, M., Eschwège, E., & Basdevant, A. (2008) · Obesity · doi:10.1038/oby.2008.285 · Cited by 229
Hepatocellular carcinoma in Budd–Chiari syndrome: characteristics and risk factors
Moucari, R., Rautou, P.-E., Cazals-Hatem, D., Geara, A., Bureau, C., Consigny, Y., Francoz, C., Denninger, M.-H., Vilgrain, V, Belghiti, J., et al. (2008) · Gut · doi:10.1136/gut.2007.139477 · Cited by 186
Self-citationPathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update
Bioulac-Sage, P., Balabaud, C., Bedossa, P., Scoazec, J. Y., Chiche, L., Dhillon, A. P., Ferrell, L., Paradis, V., Roskams, T., Vilgrain, V., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.12.007 · Cited by 181
Self-citationHistological evidence of carcinoma in a hepatic tumour associated with oral contraceptives.
Davis, M. R., Portmann, B. C., SEARLE, M., Wright, R., & Williams, R. L. (1975) · BMJ · doi:10.1136/bmj.4.5995.496 · Cited by 144
Malignant transformation of hepatic adenomas
Micchelli, S., Vivekanandan, P., Boitnott, J. K., Pawlik, T. M., Choti, M. A., & Torbenson, M. S. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.8 · Cited by 136
Evolution of Obesity Prevalence in France
Diouf, I., Charles, M.-A. A., Ducimetière, P., Basdevant, A., Eschwege, E., & Heude, B. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d5bff5 · Cited by 114
Female hormone utilisation and risk of hepatocellular carcinoma
Tavani, A., Negri, E., Parazzini, F., Franceschi, S., & Vecchia, C. L. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.116 · Cited by 76
Hepatocellular carcinoma associated with recreational anabolic steroid use: Figure 1
Gorayski, P., Thompson, C. H., Subhash, H. S., & Thomas, A. C. (2008) · British Journal of Sports Medicine · doi:10.1136/bjsm.2007.03932 · Cited by 67
Malignant transformation of hepatic adenoma with recurrence after resection
Larson, K. A., Weber, S. M., Fong, Y., et al. (2002) · HPB · doi:10.1080/136518202760388055 · Cited by 11
Cited by
Lonardo, A., Nascimbeni, F., Ballestri, S., Fairweather, D., Win, S., Than, T. A., Abdelmalek, M. F., & Suzuki, A. (2019) · Hepatology · doi:10.1002/hep.30626 · Cited by 1,050
EASL Clinical Practice Guidelines on the management of benign liver tumours
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.001 · Cited by 534
ACG Clinical Guideline: The Diagnosis and Management of Focal Liver Lesions
Marrero, J. A., Ahn, J., & Reddy, R. K. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.213 · Cited by 477
Nault, J.-C., Couchy, G., Balabaud, C., Morcrette, G., Caruso, S., Blanc, J.-F., Bacq, Y., Calderaro, J., Paradis, V., Ramos, J., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.042 · Cited by 401
Self-citationNault, J. C., Calderaro, J., Di Tommaso, L., Balabaud, C., Zafrani, E. S., Bioulac‐Sage, P., Roncalli, M., & Zucman‐Rossi, J. (2014) · Hepatology · doi:10.1002/hep.27372 · Cited by 354
Metadata
- Authors
- Farges, O., Ferreira, N., Dokmak, S., Belghiti, J., Bedossa, P., & Paradis, V.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2010-12-10
- Volume
- 60
- Issue
- 1
- Pages
- 85-89
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2113435346
- Cited by
- 299
- References
- 22
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.